Patents by Inventor Julie Partington

Julie Partington has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11534394
    Abstract: Method for treating a disease, condition, or syndrome in a subject comprising administering, to a subject in need thereof, a solid or liquid pharmaceutical composition comprising: (a) a high purity botulinum neurotoxin or a complex comprising botulinum neurotoxin, wherein the botulinum neurotoxin is of type A, B, C, D, E, F or G; and (b) a surfactant; wherein the composition does not comprise albumin or a polysaccharide.
    Type: Grant
    Filed: January 5, 2020
    Date of Patent: December 27, 2022
    Assignee: IPSEN BIOPHARM LIMITED
    Inventors: Paul Webb, Mary White, Julie Partington
  • Publication number: 20200164050
    Abstract: Method for treating a disease, condition, or syndrome in a subject comprising administering, to a subject in need thereof, a solid or liquid pharmaceutical composition comprising: (a) a high purity botulinum neurotoxin or a complex comprising botulinum neurotoxin, wherein the botulinum neurotoxin is of type A, B, C, D, E, F or G; and (b) a surfactant; wherein the composition does not comprise albumin or a polysaccharide.
    Type: Application
    Filed: January 5, 2020
    Publication date: May 28, 2020
    Applicant: IPSEN BIOPHARM LIMITED
    Inventors: Paul Webb, Mary White, Julie Partington
  • Patent number: 10561604
    Abstract: Solid and liquid pharmaceutical compositions comprising botulinum neurotoxin complex or high purity botulinum neurotoxin and a surfactant. The composition may comprise a crystalline agent.
    Type: Grant
    Filed: August 8, 2017
    Date of Patent: February 18, 2020
    Assignee: IPSEN BIOPHARM LIMITED
    Inventors: Paul Webb, Mary White, Julie Partington
  • Publication number: 20170348226
    Abstract: Solid and liquid pharmaceutical compositions comprising botulinum neurotoxin complex or high purity botulinum neurotoxin and a surfactant. The composition may comprise a crystalline agent.
    Type: Application
    Filed: August 8, 2017
    Publication date: December 7, 2017
    Applicant: Ipsen Biopharm Limited
    Inventors: Paul Webb, Mary White, Julie Partington
  • Patent number: 9757329
    Abstract: The invention relates to a solid or liquid pharmaceutical composition comprising botulinum neurotoxin complex (type A, B, C, D, E, F or G) or high purity botulinum neurotoxin (type A, B, C, D, E, F or G), and a surfactant. In particular the invention relates to a solid or liquid pharmaceutical composition comprising a crystalline agent.
    Type: Grant
    Filed: July 28, 2015
    Date of Patent: September 12, 2017
    Assignee: Ipsen Biopharm Limited
    Inventors: Paul Webb, Mary White, Julie Partington
  • Publication number: 20150328293
    Abstract: The invention relates to a solid or liquid pharmaceutical composition comprising botulinum neurotoxin complex (type A, B, C, D, E, F or G) or high purity botulinum neurotoxin (type A, B, C, D, E, F or G), and a surfactant. In particular the invention relates to a solid or liquid pharmaceutical composition comprising a crystalline agent.
    Type: Application
    Filed: July 28, 2015
    Publication date: November 19, 2015
    Inventors: Paul WEBB, Mary WHITE, Julie PARTINGTON
  • Patent number: 9125804
    Abstract: The invention relates to a solid or liquid pharmaceutical composition comprising botulinum neurotoxin complex (type A, B, C, D, E, F or G) or high purity botulinum neurotoxin (type A, B, C, D, E, F or G), and a surfactant. In particular the invention relates to a solid or liquid pharmaceutical composition comprising a crystalline agent.
    Type: Grant
    Filed: July 6, 2005
    Date of Patent: September 8, 2015
    Assignee: IPSEN BIOPHARM LIMITED
    Inventors: Paul Webb, Mary White, Julie Partington
  • Publication number: 20080050352
    Abstract: The invention relates to a solid or liquid pharmaceutical composition comprising botulinum neurotoxin complex (type A, B, C, D, E, F or G) or high purity botulinum neurotoxin (type A, B, C, D, E, F or G), and a surfactant. In particular the invention relates to a solid or liquid pharmaceutical composition comprising a crystalline agent.
    Type: Application
    Filed: July 6, 2005
    Publication date: February 28, 2008
    Inventors: Paul Webb, Mary White, Julie Partington